Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
about
Gait and behavior in an IL1β-mediated model of rat knee arthritis and effects of an IL1 antagonistSynthesis and characterization of a thermally-responsive tumor necrosis factor antagonistDisc in flames: Roles of TNF-α and IL-1β in intervertebral disc degenerationProgress in intra-articular therapyEmerging technologies for molecular therapy for intervertebral disk degenerationConstruction and application of elastin like polypeptide containing IL-4 receptor targeting peptideRecursive directional ligation by plasmid reconstruction allows rapid and seamless cloning of oligomeric genesEvaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model.Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy.Elastin-like polypeptides as a purification tag for recombinant proteins.A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds.Elastomeric polypeptide-based biomaterials.Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis.Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins.A Plant-Produced Bacteriophage Tailspike Protein for the Control of Salmonella.A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer modelsThe development and characterization of SDF1α-elastin-like-peptide nanoparticles for wound healing.Temperature sensitive peptides: engineering hyperthermia-directed therapeutics.Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugationPeptide-based Biopolymers in Biomedicine and Biotechnology.Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.Drug delivery to solid tumors by elastin-like polypeptides.Protein body-inducing fusions for high-level production and purification of recombinant proteins in plants.IL-1Ra and its delivery strategies: inserting the association in perspective.Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia.Applications of elastin-like polypeptides in drug delivery.Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.Half-life extended biotherapeutics.Elastin-like polypeptides: A strategic fusion partner for biologics.Peptide-drug conjugates as effective prodrug strategies for targeted delivery.Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.Cartilage-targeting drug delivery: can electrostatic interactions help?Biomaterial strategies for generating therapeutic immune responses.Fusions of elastin-like polypeptides to pharmaceutical proteins.Release and activity of anti-TNFalpha therapeutics from injectable chitosan preparations for local drug delivery.Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth.Tissue-engineered cartilage with inducible and tunable immunomodulatory properties.Sustained intra-articular delivery of IL-1RA from a thermally-responsive elastin-like polypeptide as a therapy for post-traumatic arthritisCharge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term
P2860
Q24631807-4CB788D8-5278-4D5D-90AD-34930E30B5B6Q24656182-537EA335-47EC-4676-B312-CF59AF119596Q26783031-5C2CBB30-90F8-403A-AEA3-1ABF9D59C169Q26851258-CC2764FA-B400-4D9A-9DDF-ADD9F44FA4C9Q27693848-114D31C7-7D88-49B5-9B7D-4796556238B5Q28536690-CDA7E2F4-7D22-4F67-A93A-22A8263FF712Q33534381-A9CA3464-118B-4D70-84B0-BA6211636509Q33634515-136742AF-4730-4C10-90CC-45C6A0C2EB6EQ33794863-CEAB9E34-63D7-43A8-9B6A-6D7E2A39E6EEQ34135836-9C35526E-62D4-4252-91C7-37B7659FB767Q34490667-45B42FD5-F370-4214-A947-2019DE09E2BDQ34508831-A3431EF4-36A1-48FA-9BFC-233478077846Q35014277-401A231A-3C63-4545-B080-2E7DF4B2C30DQ35047445-0A4887D6-61F7-418E-91F3-785F020B8827Q36162174-536BC609-C8B0-4643-9CF6-1791EB58DAE1Q36441987-3B0B00EC-9081-4E66-A276-684D1F75665CQ36580541-3FC2E808-5ADF-4820-8B55-C7EFC2690F71Q36973357-9EA40244-1827-4760-8312-27616E445FD0Q37209904-6E35BCAB-3BBF-4F7C-A46E-9291F495908FQ37241151-ED58F66D-284E-404D-9F99-F9E27524D2B8Q37362252-8B1F325F-FA1F-4E6B-BEBB-232D2756392DQ37382604-2295B0A6-D0A4-4923-BDF7-0E67AAFF1FA3Q37764989-150FD16C-D251-4193-8B2F-31E798B22AD4Q37845444-56F0C088-9547-40A6-ABC9-C0A531FEC613Q38116457-FB1EC753-A187-4D5C-B75D-8DA2E0CAA619Q38127266-C8AC1B22-C2AB-454C-892F-0BC74A467105Q38224685-A2989831-1943-4B41-B3EC-E689F870FF04Q38636559-AA3112D5-A7A8-4226-A4F8-7589FBA01801Q38770067-832587F5-BDF1-41B9-A043-DD9B9C2ED6FDQ38816648-5B023EF9-812D-49E8-85C4-FDC9555C0201Q38883760-51937D79-7546-4AF7-B70A-835D4D92BC94Q38989309-675AC3A9-907C-48F4-B31B-D082DDC560B6Q39137486-EEAEDBA8-316C-4F80-997B-54973B231626Q39271088-B1FE2F1A-15C3-4F00-B9AC-FED0DB5E728CQ39739076-9021BCBB-CE3E-4CC6-8185-6397B0E0F1CFQ39906629-8EA6FC9A-964B-47DD-A53A-32D57AE4641BQ40075759-73D01154-504F-42AD-B8C6-8F8B17C133CFQ40380301-D9236577-6B72-4FF8-93AB-583F37CEB971Q41504272-17D457F8-A665-41B1-A62A-AB85B5F85E51Q41525275-80EDC3CB-9106-4195-B9D0-92DA22B081EE
P2860
Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Development and characterizati ...... antiinflammatory therapeutic.
@ast
Development and characterizati ...... antiinflammatory therapeutic.
@en
Development and characterizati ...... antiinflammatory therapeutic.
@nl
type
label
Development and characterizati ...... antiinflammatory therapeutic.
@ast
Development and characterizati ...... antiinflammatory therapeutic.
@en
Development and characterizati ...... antiinflammatory therapeutic.
@nl
prefLabel
Development and characterizati ...... antiinflammatory therapeutic.
@ast
Development and characterizati ...... antiinflammatory therapeutic.
@en
Development and characterizati ...... antiinflammatory therapeutic.
@nl
P2093
P356
P1476
Development and characterizati ...... antiinflammatory therapeutic.
@en
P2093
Ashutosh Chilkoti
Helawe Betre
Koichi Masuda
Lori A Setton
Mohammed F Shamji
Rajeswari Pichika
P304
P356
10.1002/ART.22952
P577
2007-11-01T00:00:00Z